Related Experiment Video
Updated: Jun 6, 2026
Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis
Published on: June 26, 2016
Examining the metastatic niche: targeting the microenvironment
1Indiana University, Gatch Clinical Building, Room 459, 541 N Clinical Dr, Indianapolis, IN 46202-5111, USA. tguise@iupui.edu
Abstract:
Some of the most common cancer types, including breast cancer, prostate cancer, and lung cancer, show a predilection to metastasize to bone. The molecular basis of this preferential growth of cancer cells in the bone microenvironment has been an area of active investigation. Although the precise molecular mechanisms underlying this process remain to be elucidated, it is now increasingly being recognized that the unique characteristics of the bone niche provide homing signals to cancer cells, and create a microenvironment conducive for the cancer cells to colonize. Concomitantly, cancer cells release several regulatory factors that result in abnormal bone destruction and/or formation. This complex bidirectional interplay between tumor cells and bone microenvironment establishes a "vicious cycle" that leads to a selective growth advantage for the cancer cells. The molecular insights gained on the underpinnings of bone metastasis in recent years have also provided us with avenues to devise innovative approaches for therapeutic intervention. The goal of this review is to describe our current understanding of molecular pathophysiology of cancer metastases to bone, as well as its therapeutic implications.
Insights
Cancer cells, including breast, prostate, and lung cancer, preferentially metastasize to bone. Understanding the molecular basis of this bone metastasis is key to developing new therapies.
Area of Science:
- Oncology
- Molecular Biology
- Bone Metastasis Research
Background:
- Common cancers like breast, prostate, and lung cancer frequently metastasize to bone.
- The bone microenvironment contains signals that attract and support cancer cell colonization.
- Cancer cells disrupt bone remodeling, creating a cycle that favors tumor growth.
Purpose of the Study:
- To review the current understanding of the molecular pathophysiology of cancer metastasis to bone.
- To discuss the therapeutic implications of recent molecular insights into bone metastasis.
Main Methods:
- This review synthesizes current research on the molecular mechanisms of bone metastasis.
- It explores the bidirectional interactions between tumor cells and the bone niche.
- The review also examines emerging therapeutic strategies.
Main Results:
- The bone niche provides homing signals, promoting cancer cell colonization.
- Tumor cells induce aberrant bone remodeling (destruction/formation).
- A 'vicious cycle' is established, enhancing cancer cell growth in bone.
Conclusions:
- Molecular insights into bone metastasis are crucial for developing targeted therapies.
- Understanding the tumor-bone microenvironment interplay offers new therapeutic avenues.
- Further research into the molecular pathophysiology can lead to innovative treatments for bone metastases.
Related Concept Videos
02:17The Tumor Microenvironment
02:17The Tumor Microenvironment
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:38Mitogens and the Cell Cycle